$5.41
2.70% today
Nasdaq, Apr 03, 05:32 pm CET
ISIN
US74019L1070
Symbol
PRPO
Sector
Industry

Precipio, Inc. Stock price

$5.56
-1.71 23.54% 1M
-1.25 18.38% 6M
+0.02 0.36% YTD
-0.92 14.20% 1Y
-28.04 83.45% 3Y
-7.08 56.01% 5Y
-12,504.44 99.96% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
-0.09 1.59%
ISIN
US74019L1070
Symbol
PRPO
Sector
Industry

Key metrics

Market capitalization $8.36m
Enterprise Value $8.22m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 37.36
EV/Sales (TTM) EV/Sales 0.44
P/S ratio (TTM) P/S ratio 0.45
P/B ratio (TTM) P/B ratio 0.69
Revenue growth (TTM) Revenue growth 21.95%
Revenue (TTM) Revenue $18.53m
EBIT (operating result TTM) EBIT $-4.22m
Free Cash Flow (TTM) Free Cash Flow $220.00k
Cash position $1.39m
EPS (TTM) EPS $-2.96
Short interest 0.35%
Show more

Is Precipio, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Precipio, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Precipio, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Precipio, Inc.:

Buy
100%

Financial data from Precipio, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
19 19
22% 22%
100%
- Direct Costs 12 12
26% 26%
65%
6.52 6.52
15% 15%
35%
- Selling and Administrative Expenses 9.20 9.20
22% 22%
50%
- Research and Development Expense - -
-
-
-2.69 -2.69
56% 56%
-15%
- Depreciation and Amortization 1.53 1.53
1% 1%
8%
EBIT (Operating Income) EBIT -4.22 -4.22
45% 45%
-23%
Net Profit -4.29 -4.29
27% 27%
-23%

In millions USD.

Don't miss a Thing! We will send you all news about Precipio, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precipio, Inc. Stock News

Neutral
Seeking Alpha
3 days ago
Precipio, Inc. (NASDAQ:PRPO ) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants Operator Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update Conference Call. All participants will be in listen-only mode.
Neutral
GlobeNewsWire
17 days ago
NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st, 2025 at 5:00 PM ET.
Neutral
GlobeNewsWire
about one month ago
Both metrics demonstrate the ability to achieve financial independence Both metrics demonstrate the ability to achieve financial independence
More Precipio, Inc. News

Company Profile

Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Head office United States
CEO Ilan Danieli
Employees 60
Founded 1997
Website www.precipiodx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today